Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NKTR
NKTR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NKTR News
Nektar Therapeutics Closes $460 Million Public Offering
2d ago
Newsfilter
Nektar Therapeutics Closes $460 Million Public Offering
2d ago
PRnewswire
U.S. Stock Futures Rise as Jobless Claims Data Looms
4d ago
stocktwits
Nektar Therapeutics Prices $400M Upsized Public Offering
4d ago
seekingalpha
Nektar Therapeutics Prices $400 Million Upsized Public Offering
4d ago
PRnewswire
Nektar Therapeutics Launches $300M Public Offering
4d ago
seekingalpha
Nektar Therapeutics Stock Soars on Positive Eczema Therapy Data
4d ago
Benzinga
Nektar Therapeutics Shares Surge on Positive Atopic Dermatitis Treatment Data
5d ago
Benzinga
Datadog Beats Earnings Estimates, Shares Surge 16.3%
5d ago
Benzinga
Nektar Launches Pivotal Late-Stage Program for Atopic Dermatitis
5d ago
seekingalpha
Nektar Therapeutics Shares Surge 14% on Positive Trial Results
5d ago
stocktwits
Nektar's Rezpegaldesleukin Shows Promising Long-Term Efficacy in Atopic Dermatitis
5d ago
NASDAQ.COM
Nektar Therapeutics Reports Positive Results for Rezpegaldesleukin in Atopic Dermatitis Study
5d ago
PRnewswire
Nektar Announces Positive Results for Rezpegaldesleukin in Atopic Dermatitis Study
5d ago
Newsfilter
Nektar Therapeutics to Host Investor Call on REZOLVE-AD Trial Results
6d ago
PRnewswire
Nektar to Host Investor Call on REZOLVE-AD Results
6d ago
Newsfilter
Show More News
